CMIC：2023年日本医药市场早期药物开发和监管考量报告（英文版）

Japan is the world’s third largest pharmaceutical market after the U.S. and China. Because of factors specific to Japan, such as very quick and simple nation-wide market access and friendliness to innovative medicines, it is naturally of great interest to pharmaceutical and biotech companies when they are launching new compounds into the world market. Like all developed countries, Japan also has a strong regulatory framework, similar to the U.S. FDA, for the development and/or commercializati